Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia

被引:13
|
作者
Maugeais, C
Ouguerram, K
Frénais, R
Maugère, P
Charbonnel, B
Magot, T
Krempf, M [1 ]
机构
[1] Hotel Dieu, Clin Endocrinol, F-44093 Nantes 01, France
[2] Hotel Dieu, Ctr Rech Nute Humaine, F-44093 Nantes 01, France
来源
关键词
D O I
10.1210/jc.86.4.1679
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The acute reduction of low-density lipoprotein (LDL) cholesterol obtained by LDL-apheresis allows the role of the high level of circulating LDL on lipoprotein metabolism in heterozygous familial hypercholesterolemia (heterozygous FH) to he addressed. We studied apolipoprotein B (apoB) kinetics in five heterozygous FH patients before and the day after an apheresis treatment using endogenous labeling with [(2)H(3)]leucine. Compared with younger control subjects, heterozygous FH patients before apheresis showed a significant decrease in the fractional catabolic rate of LDL (0.24 +/- 0.08 vs. 0.65 +/- 0.22 day(-1); P < 0.01), and LDL production was increased in heterozygous FH patients (18.9 +/- 7.0 vs. 9.9 +/- 4.2 mg/kg.day; P < 0.05). The modeling of postapheresis apoB kinetics was performed using a nonsteady state condition, taking into account the changing pool size of very low density lipoprotein (VLDL), intermediate density lipoprotein, and LDL apoB. The postapheresis kinetic parameters did not show statistical differences compared with preapheresis parameters in heterozygous FH patients; however, a trend for increases in fractional catabolic rate of LDL (0.24 +/- 0.08 vs. 0.35 +/- 0.09 day(-1); P = 0.067) and the production of VLDL (13.7 +/- 8.3 vs. 21.9 +/- 1.6 mg/ kg day; P = 0.076) was observed. These results suggested that the marked decrease in plasma LDL obtained a short time after LDL-apheresis is able to stimulate LDL receptor activity and VLDL production in heterozygous FH.
引用
收藏
页码:1679 / 1686
页数:8
相关论文
共 50 条
  • [21] Polymorphisms of the low-density lipoprotein receptor gene in Brazilian individuals with heterozygous familial hypercholesterolemia
    Salazar, LA
    Cavalli, SA
    Hirata, MH
    Diament, J
    Forti, N
    Giannini, SD
    Nakandakare, ER
    Bertolami, MC
    Hirata, RDC
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2000, 33 (11) : 1301 - 1304
  • [22] Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia
    Tada, Hayato
    Nomura, Akihiro
    Nohara, Atsushi
    Usui, Soichiro
    Sakata, Kenji
    Hayashi, Kenshi
    Fujino, Noboru
    Takamura, Masayuki
    Kawashiri, Masa-aki
    ATHEROSCLEROSIS, 2023, 371 : 61 - 66
  • [23] Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia
    Tada, H.
    Nomura, A.
    Usui, S.
    Sakata, K.
    Takamura, M.
    Kawashiri, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [24] PLASMA-EXCHANGE AND LOW-DENSITY LIPOPROTEIN FILTRATION THERAPY IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    TIJHUIS, GJ
    VANDOORMAAL, JJ
    RIJSKAMP, L
    SIBINGA, CTS
    DOORENBOS, H
    PLASMA THERAPY & TRANSFUSION TECHNOLOGY, 1988, 9 (01): : 29 - 34
  • [25] Low-Density Lipoprotein Cholesterol Trajectories and Prevalence of High Low-Density Lipoprotein Cholesterol Consistent With Heterozygous Familial Hypercholesterolemia in US Children
    Zhang, Yiyi
    Woo, Jessica G.
    Urbina, Elaine M.
    Jacobs, David R., Jr.
    Moran, Andrew E.
    de Ferranti, Sarah D.
    JAMA PEDIATRICS, 2021, 175 (10) : 1071 - 1074
  • [26] APHERESIS OF LOW-DENSITY-LIPOPROTEIN IN FAMILIAL HOMOZYGOTE HYPERCHOLESTEROLEMIA
    RAHOLA, ER
    MEDICINA CLINICA, 1993, 100 (03): : 117 - 118
  • [27] Effect of Simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor
    Benítez, S
    Ordóñez-Llanos, J
    Franco, M
    Marín, C
    Paz, E
    López-Miranda, J
    Otal, C
    Pérez-Jiménez, F
    Sánchez-Quesada, JL
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (04): : 414 - 420
  • [28] Long-term effect of low-density lipoprotein apheresis: Experience in four children with familial homozygous hypercholesterolemia
    Hasanoglu, A.
    Yenicesu, I
    Eminoglu, F. T.
    Okur, I
    Tumer, L.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 127 - 127
  • [29] Low-density lipoprotein apheresis in children with familial hypercholesterolemia: Follow-up to 21 years
    Palcoux, Jean-Bernard
    Atassi-Dumont, Marielle
    Lefevre, Patrice
    Hequet, Olivier
    Schlienger, Jean-Louis
    Brignon, Pierre
    Roussel, Bernard
    THERAPEUTIC APHERESIS AND DIALYSIS, 2008, 12 (03) : 195 - 201
  • [30] Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia
    Napoli, C
    Ambrosio, G
    Scarpato, N
    Corso, G
    Palumbo, G
    DArmiento, FP
    Mancini, FP
    Malorni, A
    Formisano, S
    Ruocco, A
    Chiariello, M
    AMERICAN HEART JOURNAL, 1997, 133 (05) : 585 - 595